"Our goal with the acquisition is to integrate AI seamlessly in all aspects of our work - from target discovery, lead discovery to manufacturing and delivery of our products," BioNTech co-founder and chief executive Ugur Sahin said at the J.P. Morgan healthcare conference on Tuesday, according to Reuters."
Read More
"He previously joined the Struengmanns in backing Ganymed Pharmaceuticals AG, another firm set up by BioNTech founders Ugur Sahin and Ozlem Tureci that was sold in 2016 for as much as $1.4 billion."
Read More
"I believe a lot has changed and there is a great dealof fluidity between academia and industry in Germany and Europe," said Maria Leptin, president of the European Research Council, which is supporting BioNTech co-founder Ugur Sahin with a major grant at the Johannes Gutenberg University Mainz."
Read More
"BioNTech founder Ugur Sahin said earlier this week that the mRNA shot "should be a three-dose vaccine" to fight the new strain, and the third dose could come as early as three months after the second."
Read More
"While some places like South Korea are cutting booster timelines to just three months after the second shot -- a strategy endorsed by BioNTech SE Chief Executive Officer Ugur Sahin -- the Lancet study suggests that rushing the third dose may not be the best approach for those on inactivated vaccines like Sinovac."
Read More
"It's very clear that the Pfizer-BioNTech shot "should be a three-dose vaccine" to deal with omicron, BioNTech Chief Executive Officer Ugur Sahin said on a conference call this week. "
Read More
"Boosters could help people everywhere "get through the winter season" as the companies work on adapting the vaccine, BioNTech CEO Ugur Sahin said. "
Read More
"The initial data show a third dose could offer still offer enough protection from disease, BioNTech CEO Ugur Sahin said."
Read More
"Even if the variant is able to elude antibodies in vaccinated people, it will probably still be targeted by other components of the immune system that are activated by shots, BioNTech Chief Executive Officer Ugur Sahin said earlier this week, urging the acceleration of booster shots."
Read More
"While speaking at an event organized by Reuters on Friday,BioNTech CEO Ugur Sahin said thenew variant might be able to infect vaccinated people and people with high exposure to COVID-19."
Read More
"While the new variant might evade the antibodies generated in reaction to the vaccine, the virus will likely remain vulnerable to immune cells that destroy IT once it enters the body, BioNTech SE co-founder Ugur Sahin said."
Read More
"While the new variant might evade the antibodies generated in reaction to the vaccine, the virus will likely remain vulnerable to immune cells that destroy it once it enters the body, BioNTech SE co-founder Ugur Sahin said."
Read More
"The current generation of Covid-19 vaccines probably will still protect against severe disease in people infected by the omicron variant, BioNTech SE Chief Executive Officer Ugur Sahin said."
Read More
"The company has four programs in mid-stage clinical trials for oncology treatments, including one for high-risk colorectal cancer patients, Chief Executive Officer Ugur Sahin said in a statement. "
Read More
"We are committed to bringing our innovations to those who need them most," Chief Executive Officer Ugur Sahin said on a conference call. "
Read More
"The trial results show that "booster vaccinations could play an important role in sustaining pandemic containment and a return to normalcy," BioNTech CEO Ugur Sahin said."
Read More
"Backed by the World Health Organization, European Commission and the kENUP Foundation, the project will simultaneously seek to build out the infrastructure necessary to produce any successful malaria shot, as well as other messenger RNA vaccines, in Africa, BioNTech Chief Executive Officer Ugur Sahin said."
Read More
"The biotech firm plans to build a factory in Africa and develop a manufacturing network with local partners to transfer its technology based on messenger RNA, a genetic molecule, to a continent that has suffered from a lack of access to vaccines and other lifesaving treatment, BioNTech Chief Executive Ugur Sahin said."
Read More
"CEO Ugur Sahin said in April the company was also discussing the possibility of production in Africa."
Read More
"That's my opinion," BioNTech Chief Executive Officer Ugur Sahin said at a virtual conference held by STAT News on Tuesday."
Read More
"BioNTech SE Chief Executive Officer Ugur Sahin said Thursday that the company plans to both produce and engage in research and development of vaccines in Turkey."
Read More
"We are expanding access to new populations and geographies, and addressing emerging variants," Chief Executive Officer Ugur Sahin said in a statement."
Read More
"BioNTech Chief Executive Officer Ugur Sahin has said those who have been fully vaccinated will still likely need a booster shot of the same formulation in six to nine months. "
Read More
"One alternative to giving up patent rights would be a special license for manufacturers, Chief Executive Officer Ugur Sahin said at a briefing with journalists last week. "
Read More
"BioNTech SE Chief Executive Officer Ugur Sahin said he was confident the mRNA shot it's making with partner Pfizer Inc. would work against the India mutant though testing is still ongoing. "
Read More
"BioNTech SE, the vaccine partner of Pfizer Inc., is looking at establishing production sites in Africa and South America, Chief Executive Officer Ugur Sahin said at a briefing with members of Germany's foreign press association."
Read More
"BioNTech SE is discussing the possibility of Covid-19 vaccine production sites in Africa to expand the company's supply network in regions around the world, Chief Executive Officer Ugur Sahin said."
Read More
"We are seeing an increased demand," Chief Executive Officer Ugur Sahin said in an interview. "
Read More
"In principle, we could further increase manufacturing capacity," BioNTech CEO Ugur Sahin said Tuesday in an interview with Bloomberg TV."
Read More
"In principle, we could further increase manufacturing capacity," BioNTech CEO Ugur Sahin said Tuesday in an interview with Bloomberg TV. "
Read More
"BioNTech co-founder Ugur Sahin told Bild that initial ballpark figures were based on rough calculations of production costs before they figured out how the manufacturing would work. "
Read More
"The partners will keep looking for new formulations to make the vaccine easier to transport and use, BioNTech CEO Ugur Sahin said."
Read More
"The data submitted may facilitate the handling of our vaccine in pharmacies and provide vaccination centers an even greater flexibility," BioNTech CEO Ugur Sahin said in a news release. "
Read More
"The process in Europe certainly didn't proceed as quickly and straightforwardly as with other countries," BioNTech Chief Executive Officer Ugur Sahin told Spiegel magazine, blaming the EU's cumbersome bureaucracy and a careless approach. "
Read More
"On Monday, BioNTech CEO Ugur Sahin said at the same conference that the two companies were boosting their vaccine output goal by more than 50% in response to surging global demand."
Read More
"We are in talks about whether and how we can provide further vaccine doses from Europe for Europe this year," BioNTech Chief Executive Officer Ugur Sahin said in an e-mailed statement."
Read More
"BioNTech will increase production capacity of the vaccine it developed with Pfizer, CEO Ugur Sahin tells Der Spiegel. "
Read More
"If the virus becomes more efficient in infecting people, we might need even a higher vaccination rate to ensure that normal life can continue without interruption," BioNTech CEO Ugur Sahin were down 9.4%, while Pfizer's stock fell 1.5% and BioNTech shares dropped 7.1%. "
Read More
"In an interview with Bloomberg News on Monday, BioNTech Chief Executive Officer Ugur Sahin said he expects its shot would be effective against the strain, despite mutations in the spike protein targeted by vaccines. "
Read More
"BioNTech SE Chief Executive Officer Ugur Sahin said he's confident that the inoculation his company developed with Pfizer Inc. will work just fine against the fast-spreading coronavirus variant that's raising alarms in the U.K. and beyond. "
Read More
"The companies will probably know by January or February whether and how many additional doses can be produced, Ugur Sahin said Monday. "
Read More
"Yet, for BioNTech's founders, Ugur Sahin and Özlem Türeci, the husband-and-wife team behind the successful endeavor, it was the outcome of three decades of work, starting long before the coronavirus first appeared in humans last winter."
Read More
"Pfizer and its German partner now plan a filing with the U.S. Food and Drug Administration by Friday at the latest, BioNTech Chief Executive Officer Ugur Sahin said in a Bloomberg Television interview. "
Read More
"The hunt for a Covid-19 vaccine isn't a winner-take-all race but rather a challenge that will require more than one company to succeed, BioNTech SE's Chief Executive Officer Ugur Sahin said."
Read More
"Its stock rally has boosted the fortune of BioNTech Chief Executive Officer Ugur Sahin as well to more than $4 billion, according to the Bloomberg index, putting him on the cusp of joining the world's 500 richest people."
Read More
"About half the trial participants are elderly, and it's possible to project from the current results that the efficacy among older people should be above 80%, BioNTech Chief Executive Officer Ugur Sahin said. "
Read More
""We will need to find a way to distribute that in a fair fashion," BioNTech Chief Executive Officer Ugur Sahin said in an interview. "
Read More
""It shows that Covid-19 can be controlled," BioNTech Chief Executive Officer Ugur Sahin said in an interview. "
Read More
""We will need to find a way to distribute that in a fair fashion," BioNTech Chief Executive Officer Ugur Sahin said in an interview."
Read More
"The Bourla letter released Friday confirmed a time line laid out by BioNTech CEO Ugur Sahin this week. "
Read More
"The partners haven't had to stop their late-stage study over safety concerns, BioNTech Chief Executive Officer Ugur Sahin said in an interview. "
Read More
"Speaking at an online media briefing on the purchase of an additional German production site, Chief Executive Ugur Sahin said tests have recently confirmed the genetic compound remains stable at 2 to 8 degrees Celsius for five days but he expects storability at those conditions to be two weeks or longer."
Read More
"The site purchase from from Swiss pharma giant Novartis AG shows the German biotech's confidence in the experimental vaccine it's developing together with U.S. partner Pfizer Inc. and China's Shanghai Fosun Pharmaceutical Group Co. The site will enable BioNTech to ramp up production more quickly than if it had relied on expanding existing sites, as it had originally planned, Chief Executive Officer Ugur Sahin said in an interview late on Wednesday."
Read More
"Including study sites in Europe, "and now especially in Germany, is aimed at supporting an approval in Europe," BioNTech Chief Executive Officer Ugur Sahin said in a previous statement."
Read More